Viridian Therapeutics, Inc.\DE SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Viridian Therapeutics, Inc.\DEVRDNAug 20

   Jennifer Tousignant, insider filing for VRDN

   Jennifer Tousignant, reporting

2. ROUTINESCHEDULE 13GViridian Therapeutics, Inc.\DEVRDNAug 20

   Ownership stake disclosure by Point72 Asset Management, L.P.

   Point72 Asset Management, L.P., filed by

3. ROUTINE144Viridian Therapeutics, Inc.\DEVRDNAug 19

   Jennifer Tousignant, planned sale of VRDN shares

   Jennifer Tousignant, reporting

4. ROUTINE4Viridian Therapeutics, Inc.\DEVRDNAug 18

   Radhika Tripuraneni, insider filing for VRDN

   Radhika Tripuraneni, reporting

5. ROUTINESCHEDULE 13G/AViridian Therapeutics, Inc.\DEVRDNAug 14

   Ownership stake disclosure by Paradigm Biocapital Advisors LP (amended)

   Paradigm Biocapital Advisors LP, filed by

6. ROUTINESCHEDULE 13G/AViridian Therapeutics, Inc.\DEVRDNAug 14

   Ownership stake disclosure by Kynam Capital Management, LP (amended)

   Kynam Capital Management, LP, filed by

7. ROUTINESCHEDULE 13GViridian Therapeutics, Inc.\DEVRDNAug 14

   Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/

   PRICE T ROWE ASSOCIATES INC /MD/, filed by

8. ROUTINESCHEDULE 13G/AViridian Therapeutics, Inc.\DEVRDNAug 14

   Ownership stake disclosure by Deep Track Capital, LP (amended)

   Deep Track Capital, LP, filed by

9. ROUTINESCHEDULE 13GViridian Therapeutics, Inc.\DEVRDNAug 7

   Ownership stake disclosure by STATE STREET CORP

   STATE STREET CORP, filed by

10. NOTABLE10-QViridian Therapeutics, Inc.\DEVRDNAug 6

    Quarterly report

11. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNAug 6

    Current report

12. ROUTINE4Viridian Therapeutics, Inc.\DEVRDNJul 2

    6 insider filings

    Christopher W. Cain, insider filing for VRDN

    Show all 6

    • 4Insider filing for VRDNJul 2
    • 4Insider filing for VRDNJul 2
    • 4Insider filing for VRDNJul 2
    • 4Insider filing for VRDNJul 2
    • 4Insider filing for VRDNJul 2
    • 4Insider filing for VRDNJul 2

    Christopher W. Cain, reporting

13. ROUTINESCHEDULE 13GViridian Therapeutics, Inc.\DEVRDNJun 26

    Ownership stake disclosure by Paradigm Biocapital Advisors LP

    Paradigm Biocapital Advisors LP, filed by

14. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNJun 3

    Current report

15. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNMay 28

    Current report

16. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNMay 26

    Current report

17. ROUTINESCHEDULE 13GViridian Therapeutics, Inc.\DEVRDNMay 15

    Ownership stake disclosure by Bellevue Group AG

    Bellevue Group AG, filed by

18. ROUTINE4Viridian Therapeutics, Inc.\DEVRDNMay 13

    Fairmount Healthcare Fund II L.P., insider filing for VRDN

    Fairmount Healthcare Fund II L.P., reporting · Fairmount Funds Management LLC, reporting · +1 more

19. NOTABLESCHEDULE 13D/AViridian Therapeutics, Inc.\DEVRDNMay 13

    Ownership stake disclosure by Fairmount Funds Management LLC (amended)

    Fairmount Funds Management LLC, filed by

20. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNMay 11

    Current report

21. ROUTINESCHEDULE 13GViridian Therapeutics, Inc.\DEVRDNMay 8

    Ownership stake disclosure by Deep Track Capital, LP

    Deep Track Capital, LP, filed by

22. ROUTINE424B5Viridian Therapeutics, Inc.\DEVRDNMay 8

    2 structured-note prospectuses

    Securities offering

    Show all 2

    • 424B5Securities offeringMay 8
    • 424B5Securities offeringMay 8
23. ROUTINE305B2Viridian Therapeutics, Inc.\DEVRDNMay 7

    305B2 filing

24. ROUTINEFWPViridian Therapeutics, Inc.\DEVRDNMay 7

    2 structured-note prospectuses

    Securities offering

    Show all 2

    • FWPSecurities offeringMay 7
    • FWPSecurities offeringMay 7
25. ROUTINE424B5Viridian Therapeutics, Inc.\DEVRDNMay 6

    2 structured-note prospectuses

    Securities offering

    Show all 2

    • 424B5Securities offeringMay 6
    • 424B5Securities offeringMay 6
26. ROUTINEFWPViridian Therapeutics, Inc.\DEVRDNMay 5

    Securities offering

27. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNMay 5

    Current report

28. NOTABLE10-QViridian Therapeutics, Inc.\DEVRDNMay 5

    Quarterly report

29. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNMay 5

    Current report

30. ROUTINEARSViridian Therapeutics, Inc.\DEVRDNApr 17

    Annual report to shareholders

31. ROUTINEDEFA14AViridian Therapeutics, Inc.\DEVRDNApr 17

    Additional proxy materials

32. ROUTINEDEF 14AViridian Therapeutics, Inc.\DEVRDNApr 17

    Proxy statement

33. ROUTINE8-KViridian Therapeutics, Inc.\DEVRDNMar 30

    Current report

34. ROUTINESCHEDULE 13G/AViridian Therapeutics, Inc.\DEVRDNMar 27

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

35. ROUTINE4/AViridian Therapeutics, Inc.\DEVRDNMar 9

    4 insider filings

    Seth Harmon, insider filing for VRDN (amended)

    Show all 4

    • 4/AInsider filing for VRDN (amended)Mar 9
    • 4/AInsider filing for VRDN (amended)Mar 9
    • 4/AInsider filing for VRDN (amended)Mar 9
    • 4/AInsider filing for VRDN (amended)Mar 9

    Seth Harmon, reporting

36. ROUTINE4Viridian Therapeutics, Inc.\DEVRDNMar 4

    4 insider filings

    Jennifer Tousignant, insider filing for VRDN

    Show all 4

    • 4Insider filing for VRDNMar 4
    • 4Insider filing for VRDNMar 4
    • 4/AInsider filing for VRDN (amended)Mar 4
    • 4/AInsider filing for VRDN (amended)Mar 4

    Jennifer Tousignant, reporting

Older filings on EDGAR